Politician trade (House)

Cooper Companies (The) (COO)Rep. Gilbert Cisneros (CA31) disclosed a purchase $1K–$15K

Rep. Gilbert Cisneros (CA31) disclosed a purchase of Cooper Companies (The) in the $1K–$15K range.

$1,001–$15,000
Reported range · official band, not an exact amount
27 days
Disclosure lag
Traded
Jun 5, 2026
Disclosed
Jul 2, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Mar 27, 2026CongressDisclosed purchase of COO — reported range $1,001 - $15,000
  2. Apr 29, 20265% stakeVanguard Capital Management reported a passive stake (13G) of 7.5%
  3. May 4, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On May 4, 2026, The Cooper Companies, Inc. (the “Company”) announced that, on recommendation of the Corporate Governance & Nominating Committee, the Board of Directors of the Company (the “Board”) approved an increase in the size of the Board from nine directors to ten directors effective as of July 1, 2026, and approved the appointment of Paul Keel to fill the new director position, effective as of July 1, 2026,…”
  4. May 14, 20265% stakeCapital World Investors reported a passive stake (13G) of 4.0%
  5. May 29, 2026Congress · 1 personMembers of Congress: 2 purchases
  6. Jun 4, 2026Company filing · Form 8-K · Results, Other newsReported its results, and reported other company news
  7. Jun 5, 2026 · this disclosureCongressDisclosed purchase of COO — reported range $1,001 - $15,000

What came next

  1. Aug 11, 2026FDARecall: INCA (Infant Nasal Cannulae Assy) Neonatal Nasal CPAP, Replacement Set. Stay-Flex tubing component. 5 units per box. Model Numbers: 44-0712, 44-0707, 44-0709,…
  2. Aug 11, 2026FDARecall: INCA (Infant Nasal Cannulae Assy) Infant Nasal CPAP, Complete Set. Stay-Flex tubing component. 5 units per box. Model Numbers: 44-2707, 44-2709, 44-2710, 44-27…
  3. Aug 12, 2026FDARecall: Brand Name: Pearle Vision 1 day Product Name: (somofilcon A) Contact Lens Model/Catalog Number: Pearle Vision 1 day
  4. Aug 19, 2026FDAFDA device clearance: Wallace® Aspiration Pump (WAPV1); Wallace® Pump Filter Connector (WFC); Wallace® Vacuum Connection Kit (WVCK)
  5. Sep 9, 2026Company filing · Form 8-K · Results, Other newsReported its results, and reported other company news
  6. Sep 11, 2026Insider · 2 peopleInsiders: 2 purchases (~$629K)
  7. Sep 14, 2026Insider · 2 peopleInsiders: 2 purchases (~$702K)
  8. Sep 16, 2026Insider · 3 insiders in a week, 6th time since 2006Director purchased ~$549K of COO shares in the open market
View the official recordHouse Clerk periodic transaction report

How to read House Clerk periodic transaction report

The STOCK Act is a 2012 US law that requires members of Congress, and some senior staff, to publicly report their stock trades, and those of their spouse and dependent children, within 45 days.

Full guide: What is the STOCK Act?

What else is on file for Cooper Companies (The)

For Cooper Companies (The), OQRO holds 5 insider filings (SEC Form 4 or Form 144), 1 Congress trade report and 14 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its COO page.

Other recent filings by Rep. Gilbert Cisneros (CA31)

The full history of Rep. Gilbert Cisneros (CA31) is on the profile page.

How this filing works

Other disclosures at Cooper Companies (The)

Everything OQRO holds on this company is on its COO page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data